5 Best Quality Stocks To Watch Right Now

One of our latest value recommendations is a firm that provides top-quality pet products and services in North America; this recession-resistant industry should produce steady growth in future years, suggests J. Royden Ward, editor of Cabot Benjamin Graham Value Investor.

PetSmart (PETM) carries a broad selection of high-quality pet supplies at everyday low prices. Stores offer 10,000 items, including nationally recognized brand names, as well as an extensive selection of private brands.

In 2013, its 1,289 stores produced an industry-leading $7.0 billion in revenue. Its broad product assortment is complemented by a selection of value-added pet services; virtually all of its stores offer complete pet training services and feature pet styling salons that provide high-quality grooming services.

PetSmart emphasizes premium dog and cat foods, many of which are not available at supermarkets, warehouse clubs, or mass merchandisers. The company also offers its own brands in supermarkets and pet stores.

5 Best Recreation Stocks To Buy For 2015: Rentrak Corporation(RENT)

Rentrak Corporation, an information management company, provides content measurement and analytical services to companies in the entertainment industry. The company delivers content performance data for various entertainment platforms and media technologies, including television, theatrical, home entertainment, mobile, and broadband video. It operates in two divisions, Home Entertainment, and Advanced Media and Information. The Home Entertainment division delivers home entertainment content products, such as DVDs and blue-ray discs; and offers related rental and sales information for the content to home video specialty stores and other retailers in the United States and Canada. It leases products from various suppliers, including motion picture studios; and retailers sublease and rent these products to consumers. This division also includes direct revenue sharing (DRS) services, which encompasses the collection, tracking, auditing, and reporting of transaction and revenue data generated by DRS retailers to its respective DRS clients. The AMI division offers Essentials Suite of business information services. This division?s Essentials Suite software and services provide data collection, management, analysis, and reporting functions. It also collects and process data from across 26 countries. This division has operations in California, New York, Florida, the United Kingdom, Australia, Germany, France, Mexico, Argentina, Spain, and Russia. The company was founded in 1977 and is headquartered in Portland, Oregon with additional offices in Los Angeles, New York City, Miami/Ft. Lauderdale, Argentina, Australia, France, Germany, Mexico, Spain, and the United Kingdom.

Advisors' Opinion:

• [By Seth Jayson]

  Rentrak (Nasdaq: RENT  ) is expected to report Q4 earnings on June 13. Here's what Wall Street wants to see:

  The 10-second takeaway
  Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Rentrak's revenues will expand 12.1% and EPS will turn positive

• [By Maria Armental var popups = dojo.query(".socialByline .popC"); popups.forEach]

  Rentrak Corp.'s(RENT) revenue rose 40% with help from its television business revenue, but the box-office tracking and TV-ratings firm posted a slightly wider loss for its fiscal fourth quarter.

• [By James Oberweis]

  Rentrak (RENT) offers technology that merges television viewership, advanced demographics, and actual consumer behavior information across multiple platforms, devices, and distribution channels.

5 Best Quality Stocks To Watch Right Now: Skechers U.S.A. Inc.(SKX)

Skechers U.S.A., Inc. engages in the design, development, marketing, and distribution of footwear for men, women, and children in the United States and internationally. The company offers various products comprising casuals, such as boots, shoes, and sandals for men, as well as slip-ons, lug outsole and fashion boots, and casual sandals for women; dress casuals; relaxed fit for men; sandals; and casual fusion under the Skechers USA brand name. It also provides a line of sport footwear for men and women, including men?s lifestyle athletic footwear, lightweight women?s sneakers, and sport sandals under the Skechers Sport brand name. In addition, the company offers men?s and women?s casuals, field boots, hikers, and athletic shoes under the Skechers Work brand name; and a range of infants, toddlers, boys, and girls? boots, shoes, and sneakers under the Skechers Kids brand name. Further, its product line includes Skechers Active products, such as casual everyday and sport fusi on sneakers for females; Tone-ups and Tone-ups Fitness products comprising casual and athletic-inspired sandals for women, as well as sneakers; Shape-ups toning footwear for men and women; and Skechers Resistance Runner technical shoes for runners. Skechers U.S.A. markets its products through department and specialty stores, athletic and independent retailers, and boutiques, catalog and Internet retailers, as well as through own e-commerce Website and retail stores. As of February 15, 2011, it operated 105 concept stores, 99 factory outlet stores, and 40 warehouse outlet stores in the United States, as well as 28 concept stores and 16 factory outlets internationally. The company was founded in 1992 and is headquartered in Manhattan Beach, California.

Advisors' Opinion:

• [By Rich Smith]

  Herbalife (NYSE: HLF  ) has had a rough time of things so far this year, and things got even rougher when the multilevel marketer got sucked into an insider trading scandal at KPMG last week. When a KPMG partner was caught selling inside information on two clients he was auditing, Skechers (NYSE: SKX  ) and Herbalife, and subsequently "fired" both clients,�Skechers shares skated away unscathed -- but Herbalife lost more than $100 million in market cap.

5 Best Quality Stocks To Watch Right Now: MFS Intermediate Income Trust (MIN)

MFS Intermediate Income Trust (the Trust) is a diversified closed-end management investment company. The Trust seeks to preserve capital and provide high current income. It maintains a portfolio that includes investments in short and intermediate-term United States Government and foreign high-grade securities.

MFS Intermediate Income Trust's portfolio includes non-United States Government bonds, mortgage-backed securities, the United States Government agency securities, the United States Treasury securities, emerging market bonds, commercial mortgage-backed securities, residential mortgage-backed securities and high-grade corporate securities. The Trust can invest in foreign securities, including securities of emerging market issuers. The Trust's investment advisor is Massachusetts Financial Services Company.

Advisors' Opinion:

• [By Akaralph]

  I have written about MFS Intermediate Income Fund (MIN) on a few previous occasions, most recently here. I have extolled its virtues as a defensive play in a bear market scenario.

5 Best Quality Stocks To Watch Right Now: CEL-SCI Corp (CVM)

CEL-SCI Corporation (CEL-SCI), incorporated on March 22, 1983, is engaged in the business of Multikine cancer therapy; New cold fill manufacturing service to the pharmaceutical industry, and ligand epitope antigen presentation System (LEAPS) technology, with two products, hemagglutinin type 1 and neuraminidase type 1 (H1N1) swine flu treatment for H1N1 hospitalized patients and CEL-2000, a rheumatoid arthritis treatment vaccine.

Multikine

CEL-SCI's Multikine, is being developed for the treatment of cancer. It is a cancer immunotherapy drugs called Combination Immunotherapy because it combines active and passive immunity in one product. It is the only cancer immunotherapy that both kills cancer cells and activates the general immune system to destroy the cancer. Multikine target the tumor micro-metastases for treatment failure. Multikine is also applicable in many other solid tumors.

New Manufacturing Facility

CEL-SCI's facility manufactures Multikine for CEL-SCI's Phase III clinical trial. CEL-SCI offers the use of the facility as a service to pharmaceutical companies and others, particularly those that need to fill and finish their drugs in a cold environment. Fill and finish is the process of filling injectable drugs in a sterile manner.

LEAPS

CEL-SCI's patented T-cell Modulation Process uses heteroconjugates to direct the body to choose a specific immune response. The heteroconjugate technology, referred to as LEAPS, is intended to stimulate the human immune system to fight bacterial, viral and parasitic infections, as well as autoimmune, allergies, transplantation rejection and cancer. Administered like vaccines, LEAPS combines T-cell binding ligands with small, disease associated and peptide antigens.

Using the LEAPS technology, CEL-SCI has created a peptide treatment for H1N1 (swine flu) hospitalized patients. This LEAPS flu treatment is designed to focus on the conserved, non-changing epitopes of the di! fferent strains of Type A Influenza viruses, including swine, avian or bird, and Spanish Influenza. CEL-SCI's LEAPS flu treatment contains epitopes.

Advisors' Opinion:

• [By Bryan Murphy]

  Names like Amgen, Inc. (NASDAQ:AMGN) and CEL-SCI Corporation (NYSEMKT:CVM) may have pioneered and even mainstreamed the idea of cancer immunology, but the nature of the branch of biotechnology means any company could send CEL-SCI or Amgen back-pedaling. See, it's not about size or deep pockets in the world of biotech anymore. It's about know-how and an idea, which can just as easily be discovered and developed by a small company as they can be a large company. That's why AMGN and CVM at least need to keep a close eye on budding immunology competitor TNI Biotech Inc. (OTCMKTS:TNIB).